Roman DBDR II

The disclosure transitions the deal from operational preparation to formal regulatory solicitation, establishing the next mandatory step that will dictate the official redemption calendar and voting windows once the Form F-4 is declared effective by the SEC. Assigning committee roles and linking director compensation to sponsor founder shares creates specific incentive alignment that must be detailed in the forthcoming proxy statement, allowing investors to evaluate potential conflicts before casting redemption or voting decisions. The addition of a director with documented financial, audit, and cross-industry governance experience provides structural oversight relevant to executing a multi-gigawatt industrial combination and navigating the associated capital markets logistics.

This is the first 10-K filed after a definitive deal is signed, providing the official trust value ($10.49/share), the full terms of the merger agreement including earn-outs and the PIPE financing obligation, and the sponsor's agreement not to redeem. The compliance deadlines are set (Outside Closing Date Aug 31, 2026, extendable).

Beyond triggering the proxy solicitation timeline, the filing discloses the target’s strategic positioning, which management characterizes through stated beliefs regarding 'its position in energy markets, including with respect to AI and data centers,' alongside expectations around the 'success of its project development activities' and identification of 'suitable sustainable investment opportunities.' These thematic claims, attributed solely to management, indicate where the forthcoming Form F-4/proxy materials will likely detail customer pipelines, technology integration plans, and partnership dependencies. Material risks cited by the filing—which management acknowledges could cause results to differ materially—include reliance on 'third-party supplier and service providers,' exposure to 'political developments, laws and regulations in areas where ThomasLloyd operates,' 'increased competition,' 'supply of natural resources necessary for ThomasLloyd’s operations,' 'effects of climate change, extreme weather events, and seismic events,' and 'fluctuations in currency markets.' Because the text notes that directors and executive officers of both entities are participants in the solicitation and that their direct and indirect interests will be comprehensively tabulated in the pending Registration Statement/Proxy Statement, investors should prepare for imminent disclosure of sponsor alignment, lock-up arrangements, and potential conflicts prior to the shareholder vote.

The document advances the procedural timeline toward a Form F-4 filing and subsequent proxy mailout, establishing the prerequisite steps before a formal shareholder vote triggers any official redemption window and settlement mechanics. Capital structure transparency improves with the disclosed figures, allowing investors to model post-transaction ownership and liquidity runway, though final dilution remains pending definitive proxy details. Strategic positioning claims originate from the company statement and Chief Executive Officer Michael Sieg, who asserts the firm plans to transfer expertise cultivated since 2003—originally focused on Asian markets—into US data center projects requiring rapidly deployable renewable and energy-efficiency solutions. These forward-looking assertions are explicitly caveated by both companies’ management as assumptions subject to regulatory delays, capital-raising execution risks, currency fluctuations, climate and seismic events, and third-party supplier dependencies. The absence of precise PIPE pricing, over-allotment options, or sponsor lock-up terms in this press release means redemption floor dynamics and closing probability variables will require monitoring through the forthcoming Form F-4.

This filing sets the definitive terms for Roman DBDR's de-SPAC transaction. For redemption-tracking investors: the trust per-share value is approximately $10.54, the deadline for closing is initially August 31, 2026 (extendable to November 16, 2026 and then to December 16, 2027). There is no minimum cash condition, so redemptions do not block the deal. The Sponsor's commitment not to redeem and to vote in favor reduces redemption risk. The $100 million PIPE and $10 million convertible note targets provide additional capital. The earn-out structure aligns seller incentives with stock performance. The $200 million B. Riley equity line provides post-closing financing flexibility. The agreement contains detailed representations, warranties, and conditions typical for SPAC mergers. The filing also includes a December 2025 investor presentation with unaudited projections for ThomasLloyd (FY2024-FY2028), showing revenue growth from $44 million to $196 million and EBITDA from negative to $92 million by 2028, though management cautions these projections are outdated. Overall, this is the most critical filing for assessing the deal economics, timing, and risks.

The deal is announced, setting a valuation of $850 million for ThomasLloyd. The trust per-share value ($10.67) sets the baseline for redemptions. The sponsor's commitment not to redeem is a positive signal for deal completion. The target's financial projections are stale and explicitly disclaimed; investors should not rely on them. The agreement includes a large, aggressive earn-out structure of up to 45 million shares at escalating price targets.

The communication shifts investor focus from announcement-stage language to the forthcoming proxy mechanics and financing variables that will dictate trust utilization and deal viability. Dixon Doll, Jr. and ThomasLloyd’s management frame expectations around the implied equity value of ThomasLloyd, the anticipated amount and timing of a PIPE raise, projected redemption levels, and PubCo’s future financial condition and performance. Management attributes to ThomasLloyd internal estimates and forecasts for pipeline projects, anticipated capital expenditures, and projected success in project development activities. Management also highlights ThomasLloyd’s beliefs regarding its competitive position in energy markets, specifically citing emerging demand in AI and data centers. These projections are explicitly qualified by cited risks including regulatory approval uncertainty, increased industry competition, natural resource supply constraints, third-party dependency, currency volatility, and exposure to climate change, extreme weather, and seismic events. Roman DBDR and ThomasLloyd state neither party assumes an obligation to update these assessments, making the eventual Form F-4 and definitive proxy the authoritative source for validating management’s stated economics, testing redemption thresholds, and confirming whether financing conditions or sponsor conduct will alter the path to closing.

Trust value per share continues to accrete, but cash outside trust is very low, raising going concern risk. The 24-month deadline to complete a business combination is Dec 16, 2026; with no deal announced, time pressure is building. The CFO change may improve financial reporting reliability. The Nasdaq deficiency notice and late filing highlight past control issues. The sponsor has not yet provided additional liquidity beyond the $10K/month admin fee. Investors should monitor deal progress and potential need for extension or liquidation.

The trust value per share has grown to $10.27, exceeding the IPO price of $10.00, which is favorable for redeeming shareholders. However, the SPAC has limited cash outside trust ($618K) and a going concern warning, indicating it may struggle to fund operations until the deadline. The Nasdaq deficiency for late filing does not immediately affect listing but adds risk. The material weakness in internal controls raises governance concerns. The appointment of a new CFO may signal preparation for a deal, but no target is identified yet.

This filing does not modify redemption deadlines, trust account balances, extension procedures, or disclose target-specific merger progress; those items remain bound by the company’s original prospectus and subsequent shareholder solicitation materials. Mechanically, the compensatory framework isolates $25,000 and $50,000 outlays to an affiliate or the Sponsor rather than the trust account, preserving trust capital for potential redemptions or acquisition funding before the deadline. Birmingham’s explicit duty to prioritize the Company’s interests over the Sponsor in conflicts establishes a governance baseline for minority shareholders. Beyond executive succession and time-bound SEC reporting compensation tied to the merger window, the document contains no disclosures regarding customers, revenue, market size, strategy, technology, partnerships, or litigation. Tracking the next periodic reports will be necessary to assess trust account maintenance, warrant exercise mechanics, and formal merger vote scheduling.

While this compliance event does not alter the declared trust value, the 2026-12-16 merger deadline, or the announced deal status, the delayed 10-Q filing signals administrative friction that could postpone shareholder communications, proxy filings, or de-SPAC transaction readiness. Investors monitoring the redemption calendar and extension mechanics should verify whether the Quarterly Report is submitted well before the February 16, 2026 Nasdaq compliance window closes, as sustained exchange delinquency frequently triggers delisting hearings that may force liquidation or restructuring independent of the target acquisition process.

The filing’s Part IV narrative supplies the only near-term financial visibility for investors monitoring trust growth and sponsor cost absorption. Per John C. Small, interest earned on investments held in the Trust Account generated $2,422,595 for the three months ended June 30, 2025 and $4,709,197 for the six months ended June 30, 2025. These earnings offset formation and operating costs of $375,699 (three months) and $717,079 (six months), producing reported net incomes of $2,046,896 and $4,260,901. The first half of 2025 also recorded a $268,783 change in the fair value of an over-allotment liability. Extended reporting gaps delay transparency on trust compounding and working-capital drawdowns that directly affect per-share trust baselines and sponsor dilution calculations before deal closing.

Investors tracking redemption deadlines should note the trust per share is now $10.16, above the $10.00 IPO price, and the deadline remains December 16, 2026 (24 months from IPO closing). The company is still pre-deal, and the going concern warning indicates urgency to find a target or raise additional capital. The over-allotment exercise increased the trust size, providing more capital for a potential acquisition.

Beyond the reporting delay, the registrant declared that all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months were filed (answered "Yes"), and that no "significant change in results of operations from the corresponding period for the last fiscal year" is anticipated (answered "No"). No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or other personnel were contained in the submission. The sole substantive disclosure is CFO John C. Small’s confirmation of the accounting finalization lag and the explicit admission that exceeding the five-day grace period remains possible. This materially impacts investor oversight because delayed disclosures temporarily obscure the sponsor’s execution progress and leave cash deployment assumptions unverified until the Form 10-Q is published.

The over-allotment closure deposits an additional $30,150,000 directly into the trust account backing public shareholder redemption rights, expanding the cash pool without altering the specified redemption deadline or warrant strike price. The sponsor and underwriter co-purchase of 750,000 private warrants aligns insider capital with public investors and typically signals continued progression toward a business combination announcement. By formally listing its target sectors and publishing board composition, the Company narrows its investment mandate and provides baseline corporate governance transparency for investors monitoring whether capital accumulation and pipeline development remain on track before the 2026-12-16 deadline.

Establishes the baseline trust value of $10.05 per share, a 24-month deadline from December 16, 2024 (to December 16, 2026), and confirms sponsor indemnity for trust claims. The SPAC intends to target cybersecurity, AI, or FinTech businesses. The filing also includes a going concern qualification (pre-IPO) and details on warrants, founder shares, and the business combination marketing agreement (4.5% of gross IPO proceeds upon consummation). No target discussions have occurred to date.

The $10.05 per share initial deposit establishes the definitive baseline for redemption pricing before interest accretion or tax releases alter the pool, meaning public shareholders’ exit calculus is anchored to this exact reported figure. The fixed 24-month horizon confirms the redemption deadline without triggering extension mechanisms, shifting timing risk to management while the sponsor’s binding vote commitments and trust-replenishment promises create aligned execution incentives, albeit with acknowledged backstop limitations since the filing notes the sponsor’s assets consist solely of company securities. The unexercised over-allotment right represents latent liquidity that could increase the trust ceiling if activated before combination, whereas its absence preserves the current share count and redemption denominator. The going concern qualification signals that all non-trust working capital must prioritize transaction expenses over corporate overhead, tightening operational flexibility as the December 2026 window approaches.

This filing establishes the baseline financial structure and governance for the SPAC. The trust value of $10.67 per share (as per the provided status) and the 24-month deadline (Dec 2026) are now set. The terms of the warrants, the lock-up agreements for insiders and sponsor, and the transfer restrictions on private placement warrants are all defined. The focus on cybersecurity, AI, or fintech is stated. The underwriter, B. Riley Securities, is entitled to a 4.5% business combination marketing fee, which may influence deal economics.

Establishes all key terms for this SPAC: trust value ($10.05/share), 24-month deadline, redemption mechanics, sponsor incentives (founder shares at ~$0.003/share), potential dilution from private placement warrants and founder share conversion, and conflicts of interest. Investors need this baseline to monitor future extensions, deal announcements, and redemption events.

Because the Form 3 contains zero reported activity, it offers no data on customer acquisition, revenue milestones, market share positioning, technology validation, strategic partnerships, ongoing litigation, or executive personnel movements. For investors monitoring the redemption timeline, trust balance, extension triggers, deal progress, and sponsor alignment, the clean disclosure verifies baseline regulatory compliance without indicating defensive share accumulation, exit liquidity preparation, or contingent planning. The absence of transactional activity means merger vote thresholds, potential extension mechanics, and cash-at-risk projections remain fully aligned with previously disclosed parameters.

Pulling back on the acceleration request freezes the administrative and capital-deployment mechanics tied to the announced transaction, delaying definitive proxy distribution, underwriting proceeds, and any shareholder redemption settlements contingent on that effectiveness. Because the SPAC’s status is DEAL_ANNOUNCED, redemption deadlines have not yet triggered, but the pause signals sponsor-level deferral pending unstated operational or market conditions. Investors tracking execution cadence, extension triggers, and sponsor conduct should monitor for subsequent correspondence indicating whether the S-1 acceleration will be refiled, or whether the entity will prepare a formal extension amendment before the 2026-12-16 deadline. As stated by Mr. Doll, the withdrawal applies until further notice.

Although this is an IPO-stage filing (not a deal filing), it is material because it establishes the trust value ($10.05/share), the redemption deadline (24 months from closing, likely late 2026), and the sponsor's cost basis (~$0.003/share). Investors tracking redemption mechanics and sponsor incentives should note the very low sponsor cost basis creates a substantial profit incentive even if the post-business-combination stock declines. The filing also details the non-managing sponsor investors' arrangement and the 15% cap on redemptions per shareholder if a vote is held.

Acceleration of the IPO registration statement initiates the pricing and listing phase, which directly triggers the public trading cycle and establishes the baseline calendar for shareholder redemption evaluations. As stated in the filing, an earlier effective date reduces the runway available before the announced business combination deadline, meaning the sponsor and management team must complete target due diligence, finalize binding agreement terms, and satisfy financing conditions within a compressed timeframe. Failure to advance accordingly could trigger liquidation protocols or require an extension vote under the existing prospectus framework. The document contains no additional operational claims, customer metrics, revenue projections, technology descriptions, partnership disclosures, or litigation updates beyond standard executive signing authority.

This filing establishes the final pricing and capital structure of the SPAC. The presence of large, non-binding expressions of interest from institutional investors that would also receive a substantial block of founder shares at a nominal price is a material governance and incentive detail. The trust value of $10.05 per share provides the baseline for any future redemption. The 24-month deadline sets the timeline for deal execution. The document also confirms the sponsor's extremely low cost basis for its founder shares ($0.003 per share) and details the mechanisms for dilution.

What changed: Routine compliance exhibit consisting of two Limited Powers of Attorney authorizing designated agents to execute Form 13G filings pursuant to the Securities Exchange Act of 1934. The filing reports no alterations to redemption deadlines, trust value per share, extension timelines, merger deal progress, or sponsor conduct. There are no updates to capital account structures, shareholder withdrawal mechanics, or business combination schedules. Why it matters: The document operates strictly as an administrative authorization granting Takahiro Katsura power to submit Section 13(d) and Section 13(g) disclosures for Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC. Because it contains only procedural language, corporate titles, and principal business addresses signed by Shuji Matsuura and Adam Hopkins on 8-13-2026, it conveys zero material information regarding target customers, revenue streams, market sizing, strategic roadmaps, technology assets, commercial partnerships, active litigation, or operational personnel changes. Investors seeking actual equity position data must review the accompanying Schedule 13G body, as this exhibit does not independently affect SPAC liquidity conditions or transaction milestones.

What changed: Schedule 13G beneficial ownership report. The filing reports no updates affecting redemption deadlines, trust value, extensions, deal progress, or sponsor conduct. Why it matters: It also contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Filed solely to disclose Barclays PLC’s equity position, the document does not alter SPAC capital structure, business combination timelines, or shareholder rights.

What changed: Schedule 13G — a routine compliance exhibit and statutory beneficial ownership report filed to disclose equity holdings in DRDB. The provided filing text identifies Glazer Capital, LLC and Paul J. Glazer as the reporting persons. It contains no statements altering redemption deadlines, trust value, extension options, deal progress, or sponsor conduct. Furthermore, it includes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; therefore, no factual assertions require attribution. Why it matters: As a standard Section 13(d) filing, this submission does not impact the stated $10.67 per share trust balance or the December 16, 2026 liquidation timeline. Because the document reports only holder identity and lacks operative transaction language, it does not trigger redemption windows, voting requirements, or merger milestones. Investors tracking SPAC mechanics should monitor forthcoming proxy statements, merger agreements, or tender offer announcements for binding updates.

What changed: Quarterly report (Form 10-Q) for Roman DBDR Acquisition Corp. II for the period ended June 30, 2026, filed August 6, 2026. Trust per-share value increased from $10.49 at Dec 31, 2025 to $10.67 at June 30, 2026, reflecting $4.29M interest earned in H1 2026. Cash outside trust shrank from $183k to $66k. Sponsor promissory notes outstanding rose from $200k to $580k (new $280k note in Feb 2026 and $100k note in June 2026). General and administrative expenses surged to $2.32M in H1 2026 from $736k in H1 2025, reflecting deal-related costs. Net income fell to $1.97M from $4.24M year-over-year due to higher expenses and no over-allotment liability change. Directors James Nevels and Michael Woods resigned; Randolph Read and Hunter Gary appointed. CFO John Birmingham extended via addendum with $25k payment. Placement agents Lucid and Berenberg engaged for a proposed private placement to fund the ThomasLloyd deal. The ThomasLloyd Business Combination Agreement remains unchanged, expected to close in second half 2026; no extension or deadline change. Going concern disclosure remains, citing low liquidity and dependence on consummating a business combination. Why it matters: Trust value continues to grow, but cash burn is accelerating with $2.32M in expenses year-to-date, signaling rising deal costs. The sponsor is funding working capital via promissory notes, indicating tight liquidity. The new placement agent agreements suggest efforts to secure backstop or PIPE financing for the ThomasLloyd deal. Director turnover and CFO extension reflect preparations for closing. The trust per-share of $10.67 sets the redemption floor; no redemptions have occurred yet. Investors should monitor whether the deal closes before the December 16, 2026 deadline and whether additional financing is secured.

What changed: Form 8-K current report under Item 5.02 disclosing a compensatory arrangement and executive employment extension. On May 27, 2026, Roman DBDR Acquisition Corp. II and Chief Financial Officer John J. Birmingham executed an Addendum extending his employment term until the earliest of mutual termination, consummation of the initial business combination, corporate winding up, or removal. Per the agreement signed by Chief Executive Officer Dixon Doll, Jr., Mr. Birmingham receives a one-time cash payment of USD$25,000 covering remaining SEC reporting duties—including the business combination registration statement and the Q2 2026 10Q—scheduled for payment on July 1, 2026. The filing notes that compensation may be disbursed by the sponsor, Roman DBDR Acquisition Sponsor II LLC, and retains mutual discretion to negotiate additional payments for future financial diligence and modeling services tied to the initial business combination. Why it matters: Tying the CFO’s employment duration to transaction close or liquidation confirms administrative momentum toward securing the initial business combination and preparing required SEC disclosures, rather than preparing for trust distribution. The sponsorship of the $25,000 payout demonstrates ongoing sponsor funding for compliance infrastructure, while the carve-out for future diligence payments signals anticipated pre-close expenditures. Executively anchored to the deal timeline, the Addendum reduces execution risk for pending filings and reinforces sponsor confidence in advancing toward a merger before any forced dissolution event.

What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026. Trust account per share $10.56 (up from $10.49 at year-end 2025) on 23M public shares; net loss $235,067 vs net income $2.2M in Q1 2025 due to higher G&A ($1.9M vs $0.3M) and lower trust interest; cash dropped to $53,490 from $183,022; sponsor promissory note increased to $480,000; going concern uncertainty reiterated. Business Combination Agreement with ThomasLloyd signed Feb 27, 2026 (expected close H2 2026). After quarter end: engaged Lucid and Berenberg as placement agents for a private placement to fund the deal; directors Nevels and Woods resigned, Read and Gary appointed. Why it matters: First quarterly report since deal announcement; shows deteriorating cash position and reliance on sponsor loans, highlighting urgency to close. Trust per share $10.56 provides redemption baseline. Details of ThomasLloyd deal (equity valued at $850M), CEF up to $200M, and new PIPE efforts through Lucid/Berenberg are critical for assessing probability of completion. Director changes may signal preparation for post-closing governance. Material weakness in internal controls remains.

What changed: A Schedule 13G beneficial ownership report filed by Highbridge Capital Management, LLC. Routine compliance exhibit. The excerpt reports no updates regarding redemption deadlines, trust share value, extension proposals, business combination progress, or sponsor conduct. Why it matters: Attributed solely to Highbridge Capital Management, LLC, this filing satisfies SEC Section 13(d) reporting obligations. Because the text omits beneficial ownership percentages, acquisition dates, and stated purposes, it signals neither increased redemption pressure ahead of the December 16, 2026 deadline nor measurable shifts in deal advancement. No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are presented in the document.

What changed: A current report on Form 8-K disclosing executive and director departures and appointments in connection with preparations for a proposed business combination. On May 11, 2026, Michael Woods resigned as a director, effective immediately. The Board simultaneously appointed Hunter C. Gary as an independent director and member of the Compensation Committee; Gary will receive an indirect interest in the company's founder shares through membership interests in the sponsor. On May 14, 2026, Chief Technology Officer Dr. Donald G. Basile resigned, effective immediately, and Al Basseri was appointed as the new CTO. These personnel updates do not modify the redemption calendar, extend the deadline, alter the trust per-share value of $10.67, or amend the underlying merger agreement terms or mechanics. Why it matters: The filings and accompanying Exhibit 99.1 press release signal progression toward filing a Registration Statement on Form F-4 to solicit shareholder votes for the proposed business combination with ThomasLloyd Climate Solutions B.V. Chairman and CEO Dixon Doll, Jr. stated in the press release that the leadership additions will drive operational excellence and support strategic technology initiatives ahead of the combination. The press release describes ThomasLloyd as a vertically integrated sustainable energy and technology solutions provider that has collectively structured, managed, and operated 115 projects across more than 20 countries, representing approximately 28 gigawatts of power generation capacity. The filing also references the sponsor's track record, noting Roman DBDR Tech Acquisition Corp raised US$236 million, completed a merger with CompoSecure Holdings in December 2021 that included a US$175 million fully committed exchangeable notes and common stock PIPE financing led by funds and accounts managed by BlackRock and Highbridge Capital Management, and notes CompoSecure's January 2026 merger with Husky Technologies Limited. This update advances transaction visibility and target-scale disclosure while leaving redemption rights and the $10.67 trust intact for investors tracking the 2026-12-16 deadline.

What changed: SEC Form 3 — Insider Ownership Report (routine compliance exhibit). FIRST, the document is a standard regulatory filing requiring corporate insiders to disclose equity positions. THEN, it reports that director Gary Hunter Clark executed no non-derivative transactions and holds no reportable holdings during the covered period. Accordingly, there is no change to insider alignment, and the submission bears no mechanical impact on redemption deadlines, trust value, extension requests, deal progress, or sponsor conduct. THEN, the document contains no attributable claims from management, sponsors, or third parties regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or future operations; it functions purely as a compliance ledger confirming adherence to Section 16 reporting rules without introducing new commercial or structural variables. Why it matters: For investors monitoring the SPAC lifecycle, this confirmation of zero insider movement eliminates directional trading signals that could otherwise suggest shifting conviction relative to the pending business combination. It verifies regulatory compliance while leaving redemption thresholds, trust accounting, and the announced deal timeline entirely unaffected. Although it introduces no operational or financial updates, establishing a clean ownership baseline prevents post-closing disclosure disputes and ensures transparent tracking of director-level exposure through the closing window.